Table 1

Characteristics of the 11 individuals with a germline MLH1 variant from 12 colorectal carcinomas with loss of PMS2 expression and retained MLH1 expression

Tumour #GenderAge, yearsAmsterdam criteriaTumour locationVariantProteinInSiGHT classification
1Female40NoneDescendingc.230G>Ap.Cys77TyrClass 5
2*Male44NoneDescendingc.113A>Gp.Asn38SerClass 5
3*Male40IRectumc.113A>Gp.Asn38SerClass 5
4Female51IDescendingc.790+1G>Ap.Glu227_Ser295delClass 5
5†Male34IICecumc.677+3A>Gp.Gln197Argfs*8Class 5
6†Male34IIRectumc.677+3A>Gp.Gln197Argfs*8Class 5
7Male63ICaecumc.2195_2198dupp.His733Glnfs*14Class 5
8Male49NoneUnknownc.230G>Ap.Cys77TyrClass 5
9Female33NoneRectumc.199G>Ap.Gly67ArgClass 5
10Male62IITransversec.374C>Ap.Ala125GluUV
11Male24NoneAscendingc.187G>Cp.Asp63HisUV
12Male38ICecumc.187G>Cp.Asp63HisUV
  • UV: unclassified variant by InSiGHT. These UVs were predicted to be damaging through in silico analysis.

  • *Cousins.

  • †2×colorectal carcinomas from the same individual.